Federal Circuit Vacates & Remands Flow-Through Oxygenator Patent Case
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Tennant Co. v. Oxygenator Water Technologies, Inc. |
| Case Number | 2022-2304 (Fed. Cir.) |
| Court | Federal Circuit, Appeal from District Court |
| Duration | Sept 2022 – July 2024 1 year 10 months |
| Outcome | VACATED & REMANDED |
| Patents at Issue | |
| Accused Products | Flow-through oxygenator technology |
Case Overview
The Parties
⚖️ Plaintiff
A well-established industrial cleaning and water treatment equipment manufacturer with a notable intellectual property portfolio in fluid management technologies.
🛡️ Defendant
A company operating in the water oxygenation technology space, facing challenges to its product line based on Tennant’s reissue patent claims.
Patent at Issue
The central patent in this case is **U.S. Reissue Patent RE45,415E** (corrected application number US13/247241), which covers a **flow-through oxygenator** — a device designed to infuse oxygen into flowing water or fluid streams. Reissue patents, granted under 35 U.S.C. § 251, represent corrected or broadened versions of originally issued patents, making them frequent targets for validity challenges.
- • US RE45,415E — Flow-through oxygenator for infusing oxygen into fluid streams.
Designing a similar water treatment product?
Check if your flow-through oxygenator design might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
The Federal Circuit issued an order of **VACATED AND REMANDED**, meaning the appellate court neither affirmed the lower tribunal’s findings nor entered a final judgment on the merits. Instead, it determined that the prior decision contained legal errors or insufficiently addressed key issues — requiring the lower court or tribunal to reconsider the matter under corrected legal standards.
Key Legal Issues
The Federal Circuit’s decision to vacate and remand suggests the lower tribunal may have applied an incorrect legal standard, failed to adequately address specific claim validity arguments, or issued findings insufficiently supported by the record. Challenges to reissue patents often involve the **recapture doctrine**, which bars patentees from reclaiming through reissue the subject matter intentionally surrendered during original prosecution, or traditional § 102 anticipation or § 103 obviousness arguments against the reissued claims.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in water treatment technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View related patents in this technology space
- See which companies are most active in water oxygenation patents
- Understand invalidity challenges against reissue patents
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
Reissue Patent Vulnerability
Heightened scrutiny on appeal
RE45,415E Validity Unsettled
Ongoing uncertainty for market
Litigation Leverage Gained
Opportunity to strengthen invalidity claims
✅ Key Takeaways
The Federal Circuit’s vacatur signals unresolved legal error in lower patentability analysis — analyze the remand order closely.
Search related case law →Reissue patent invalidity cases demand exhaustive record development at the trial level to avoid appellate reversal on procedural grounds.
Explore precedents →Frequently Asked Questions
The case involved U.S. Reissue Patent RE45,415E (application number US13/247241), covering flow-through oxygenator technology.
The Federal Circuit vacated and remanded the lower court’s decision on patentability grounds, requiring further proceedings without issuing a final merits judgment.
The unresolved validity of RE45,415E creates ongoing uncertainty for competitors. Companies in the water oxygenation space should update FTO analyses and monitor remand proceedings closely.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- United States Court of Appeals for the Federal Circuit — Case 22-2304
- USPTO Patent Center – RE45415E
- PACER Case Docket 22-2304
- Cornell Legal Information Institute — 35 U.S.C. § 251
- Cornell Legal Information Institute — 35 U.S.C. § 102
- Cornell Legal Information Institute — 35 U.S.C. § 103
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.